Most of these peptides are still in the research phase and not approved for human use
Learn more about metabolic health and virtual care at Carebridge Medical: www.mycarebridgemed.com #MetabolicHealth #ObesityMedicine #GLP1 #WeightLossMedicine To view or add a comment, sign in Since our global oral first-in-class Type 2 diabetes, dorzagliatin, was approved in 2022 and included in the National Reimbursement Drug List in Jan 2024 in China, access and use has been increasing rapidly in mainland China
Current medical guidelines recommend discontinuing semaglutide as soon as pregnancy is confirmed, ideally within the first few weeks
Wang, T., Yang, W., Karakas, S
"I've noticed an increase in my day-to-day happiness," Rebecca brightly noted, "and my resilience to challenges is better." Robert's experience echoes this sentiment
#Retatrutide #Semaglutide #Tirzepatide #GLP1 #ObesityMedicine #LongevityMedicine #MetabolicHealth #Peptides To view or add a comment, sign in The next generation of obesity drugs will not be measured by how much weight a patient loses